Gastrointestinal Neoplasms
"Gastrointestinal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL.
| Descriptor ID |
D005770
|
| MeSH Number(s) |
C04.588.274.476 C06.301.371 C06.405.249
|
| Concept/Terms |
Gastrointestinal Neoplasms- Gastrointestinal Neoplasms
- Gastrointestinal Neoplasm
- Neoplasm, Gastrointestinal
- Neoplasms, Gastrointestinal
Cancer of Gastrointestinal Tract- Cancer of Gastrointestinal Tract
- Gastrointestinal Tract Cancer
- Gastrointestinal Tract Cancers
- Cancer of the Gastrointestinal Tract
- Gastrointestinal Cancer
- Cancer, Gastrointestinal
- Cancers, Gastrointestinal
- Gastrointestinal Cancers
|
Below are MeSH descriptors whose meaning is more general than "Gastrointestinal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Gastrointestinal Neoplasms".
This graph shows the total number of publications written about "Gastrointestinal Neoplasms" by people in this website by year, and whether "Gastrointestinal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 |
| 1998 | 4 | 0 | 4 |
| 1999 | 4 | 0 | 4 |
| 2000 | 4 | 1 | 5 |
| 2001 | 8 | 1 | 9 |
| 2002 | 7 | 0 | 7 |
| 2003 | 10 | 1 | 11 |
| 2004 | 3 | 0 | 3 |
| 2005 | 3 | 1 | 4 |
| 2006 | 3 | 0 | 3 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2012 | 4 | 0 | 4 |
| 2013 | 5 | 0 | 5 |
| 2014 | 3 | 0 | 3 |
| 2015 | 2 | 0 | 2 |
| 2016 | 5 | 1 | 6 |
| 2017 | 2 | 0 | 2 |
| 2018 | 2 | 0 | 2 |
| 2019 | 3 | 0 | 3 |
| 2020 | 0 | 1 | 1 |
| 2021 | 5 | 0 | 5 |
| 2022 | 4 | 0 | 4 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gastrointestinal Neoplasms" by people in Profiles.
-
Loftus AW, Hue JJ, Elshami M, Miller-Ocuin JL, Steinhagen E, Hoehn RS, Rothermel LD, Ammori JB, Hardacre JM, Ocuin LM. An Age-Stratified Analysis of Early Postoperative Mortality Among Medicare-Eligible Patients With Common Gastrointestinal and Hepato-pancreato-biliary Malignancies. Am Surg. 2024 Nov; 90(11):2940-2950.
-
Staudt RE, Carlson RD, Snook AE. Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy. Cancer Biol Ther. 2022 12 31; 23(1):127-133.
-
Yeo TP, Cannaday S, Thompson RE, Fogg R, Nevler A, Lavu H, Yeo CJ. Distress, Depression, and the Effect of ZIP Code in Pancreaticobiliary Cancer Patients and Their Significant Others. J Am Coll Surg. 2023 02 01; 236(2):339-349.
-
Kamaya A, Fung C, Szpakowski JL, Fetzer DT, Walsh AJ, Alimi Y, Bingham DB, Corwin MT, Dahiya N, Gabriel H, Park WG, Porembka MR, Rodgers SK, Tublin ME, Yuan X, Zhang Y, Middleton WD. Management of Incidentally Detected Gallbladder Polyps: Society of Radiologists in Ultrasound Consensus Conference Recommendations. Radiology. 2022 11; 305(2):277-289.
-
Lefler DS, Snook AE, Bashir B. Immune checkpoint inhibitors in luminal gastrointestinal malignancies: going beyond MSI-H/dMMR, TMB?and PD-L1. Immunotherapy. 2022 08; 14(11):885-902.
-
Yeo TP, Fogg RW, Shimada A, Marchesani N, Lavu H, Nevler A, Hegarty S, Brody JR, Yeo CJ. The Imperative of Assessing Quality of Life in Patients Presenting to a Pancreaticobiliary Surgery Clinic. Ann Surg. 2023 Jan 01; 277(1):e136-e143.
-
Entezari AA, Snook AE, Waldman SA. Guanylyl cyclase 2C (GUCY2C) in gastrointestinal cancers: recent innovations and therapeutic potential. Expert Opin Ther Targets. 2021 05; 25(5):335-346.
-
Hitscherich KJ, Garg M, Petrelli NJ, Bennett JJ. Characteristics of Gastrointestinal Stromal Tumors incidentally discovered during abdominal surgery. Am J Surg. 2021 Nov; 222(5):983-988.
-
Bashir B, Flickinger JC, Snook AE. Vaccines and immune checkpoint inhibitors: a promising combination strategy in gastrointestinal cancers. Immunotherapy. 2021 05; 13(7):561-564.
-
Flickinger JC, Rappaport JA, Barton JR, Baybutt TR, Pattison AM, Snook AE, Waldman SA. Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies. Biomark Med. 2021 Feb; 15(3):201-217.